z-logo
Premium
WS09‐05Sonographic appearance of borderline ovarian tumors
Author(s) -
Exacoustòs C.,
Rinaldo D.,
Carusotti C.,
Arduini D.,
Romanini C.
Publication year - 2000
Publication title -
ultrasound in obstetrics and gynecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.202
H-Index - 141
eISSN - 1469-0705
pISSN - 0960-7692
DOI - 10.1046/j.1469-0705.2000.00009-1-58.x
Subject(s) - medicine , serous fluid , pathology , ovary , cyst
Background The aim of the present study is to individuate sonographic markers which make it possible to distinguish borderline ovarian tumors from benign and malignant cysts, thus allowing conservative treatment. Method We reviewed transvaginal sonograms in 23 women who presented borderline ovarian tumors histologically confirmed. Sixteen were premenopausal and 7 postmenopausal. The size and morphologic criteria of each mass and color flow Doppler characteristics were evaluated. We compared these findings with those of 337 patients with benign ovarian tumors and those of 40 patients with malignant ovarian tumors. Results Of the 16 borderline ovarian tumors in premenopause 6 were mucinous cystoadenomas and 10 serous cystoadenomas. Of the 7 borderline tumors in postmenopause 3 were mucinous cystoadenomas and 4 serous cystoadenomas. The analysis of grey scale morphologic findings revealed the presence of solid tissue in 92.5% of malignant masses, in 13.3% of benign tumors ( P  < 0.01) and in 31% of LMP tumors ( P  < 0.01 vs. malignant, P = n .s vs. benign tumors). The presence of papillae within the cysts was significantly higher in borderline tumors (21%) compared to benign and malignant tumors. Three unilocular cysts with a diameter > 5 cm were borderline tumors. Conclusion The most frequent diagnostic imaging was that of a papillae inside a cyst without other signs of complexity and also the presence of septa was frequent. Neither papillae nor septa constituted sensitive sonographic markers.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here